Our findings are consistent with those of Kraan and coworkers who found that the numbers of CD38+ plasma cells and CD22+ B cells in RA were the best discriminating markers when comparing RA to non-RA inflammatory synovial samples [22]. This evidence concerns the gene CD22 and rheumatoid arthritis.